Monsanto Roundup Lawsuit

Thursday, September 01, 2011

Glaxo in the Dock Again For Paxil Birth Defects

Image: drugawareness.org


GlaxoSmithKline, the company that professes to make you "do more, feel better and live longer" are back in the dock, this time in Vancouver, British Columbia, Canada.


Faith Gibson gave birth to her daughter only to find out that she was born with a heart defect. Gibson's lawsuit claims that GlaxoSmithKline failed to provide adequate information regarding the risks of birth defects for women taking Paxil during pregnancy.

The Vancouver Sun reports that a Judge has ruled that Gibson does not have to disclose her medical records before a class-action certification, her trial is a lead case in an as yet unheard class-action certification application.

The Vancouver Sun writes:

Gibson's daughter Meah was born six years ago with a hole in her heart, which required surgery and seven months of hospital visits

Three months after Meah was born, the U.S. Federal Drug Administration issued a warning for an elevated risk of cardiovascular birth defects for children of women taking Paxil during pregnancy.

Gibson's lawsuit alleges that the drug maker knew or ought to have known as early as June 2003 that there was a significant risk of serious adverse cardiovascular complication for newborns from pregnant mothers taking Paxil.

It further claims that the drug maker failed to publicize the problem and failed to apprise Gibson or her physicians of the inherent dangers.

If successful it could mean that any person in Canada, born with cardiovascular defects, to women who ingested Paxil while pregnant, and the mothers of those persons could be eligible for compensation.

The pending case echoes that of Lyam Kilker, a child born with heart defects after his mother ingested Paxil during pregnancy. GlaxoSmithKline lost that trial when a jury found, by a majority of 10-2, that Lyam's heart defects were a result of Paxil use by his mother. Glaxo appealed the decision then quietly settled an estimated further 800 cases claiming Paxil had caused children to be born with defects. Rumour has it that they eventually dropped the appeal against the Kilker family and also settled 'out-of-court.'

Paxil is a clear teratogen, something the British drug regulator refuse to acknowledge despite being provided by me with the court documents from the Kilker trial. The documents can be found on my sister blog GlaxoSmithKline Internal Files HERE.




Fid 


ORDER THE PAPERBACK 'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman US and CANADA HERE OR UK FROM CHIPMUNKA PUBLISHING 


AUSTRALIAN ORDERS HERE